Science‘Just the start of a wave’: The promise of mRNA cancer vaccines

Moderna and Merck have reported a breakthrough in a personalised mRNA cancer vaccine. A large late-stage trial found it outperformed standard treatment in melanoma patients. Seth Cheetham of the Australian Personalised mRNA Cancer Immunotherapy Hub explains how the vaccine uses a tumour’s unique genetic blueprint to train the immune system to identify and attack cancer cells.